The University of Arizona Center for Health Sciences, with strong support from the Maricopa County Board of Supervisors, announced $4 million in funding for a developing Life Sciences Innovation Hub at the Phoenix Bioscience Core, Arizona, June 28. Approved the offer. downtown phoenix.
The Center for Advanced Molecular and Immunological Therapies (CAMI) is based on the belief that the body’s natural immune system is the most effective defense against health problems. CAMI advances our knowledge of the immunology of cancer, infectious diseases, and autoimmune diseases. The goal is to develop novel strategies for diagnosing, preventing, and treating diseases such as COVID-19 and long-term COVID-19.
“The Center for Advanced Molecular Immunotherapy is designed to respond to past and future health crises, advance medical action within the region, and provide additional fuel to the region’s economic engine. “We are doing it,” said Michael D. Dake, M.D., Senior Vice President of Health Sciences, University of Arizona. “This financial investment from the Maricopa County Board of Supervisors will allow CAMI to expand Phoenix into cell- and gene-based therapeutics research, start-up activities, and corporate engagement.”
The $4 million investment comes from federal funding provided to Maricopa County through the American Rescue Planning Act (ARPA). Over the past two years, the county has used these federal recovery funds to keep people at home, keep small businesses running, track and mitigate the spread of COVID-19, and save money through new housing and health care. It has provided financial assistance to strengthen the region’s infrastructure. care efforts.Maricopa County is committed to Distribute ARPA funds equitably It focuses on the most vulnerable populations and areas disproportionately affected by COVID-19. His investment in CAMI for design, construction and project management is fully aligned with Maricopa County’s broader goals.
Maricopa County Supervisory Board Chairman Clint Hickman (District 4) said, “There is a need to research novel immunotherapies to combat the ongoing impact of COVID-19, especially among the most vulnerable populations. There is a strong need to expand the Sciences and CAMI is aligned with our commitment to improving the health of Arizona residents while providing significant tangible financial benefits to Maricopa County and the state. We are proud to help welcome CAMI to Phoenix. ”
The work of CAMI researchers will support the health of underserved communities and address the disproportionate impact of current and future pandemics on the most vulnerable Arizonans. Studying the underlying causes of disease susceptibility and developing an immune profile for Arizonas at high risk of infection will provide targeted, precision-based therapies to protect Arizona’s most vulnerable populations. may lead to the development of
With an estimated 2.5:1 return on investment over the first 10 years, CAMI expects to add at least $3.9 billion to Arizona’s economic activity and at least $140 million in new local tax revenues for Maricopa County and Phoenix It has been. . With a population of 4.5 million, Maricopa County is the fourth largest and fastest growing county in the nation, according to the U.S. Census Bureau.
CAMI was initiated with New Economy Initiative funding provided to the University of Arizona by the State Legislature and allocated to the University of Arizona Health Sciences. It has strong government and philanthropic support, including $150 million in state funding announced last year.
